Christian Rolfo, M., Laurent Greillier, M., Remi Veillon, M., Firas Badin, M., Francois Ghiringhelli, M., Nicolas Isambert, M., . . . Sandrine Hiret, M. Efficacy and Safety of Bintrafusp Alfa, a Bifunctional Fusion Protein Targeting Transforming Growth Factor-β and Programmed Death-Ligand 1, Plus Chemotherapy in Patients With Stage IV NSCLC. Elsevier.
Chicago Style (17th ed.) CitationChristian Rolfo, MD, et al. Efficacy and Safety of Bintrafusp Alfa, a Bifunctional Fusion Protein Targeting Transforming Growth Factor-β and Programmed Death-Ligand 1, Plus Chemotherapy in Patients With Stage IV NSCLC. Elsevier.
MLA (9th ed.) CitationChristian Rolfo, MD, et al. Efficacy and Safety of Bintrafusp Alfa, a Bifunctional Fusion Protein Targeting Transforming Growth Factor-β and Programmed Death-Ligand 1, Plus Chemotherapy in Patients With Stage IV NSCLC. Elsevier.